Hinge Health is trading at $95.50, up 4.31% in after-hours trading following several positive developments: * Truist raised its price target to $112 from $85, maintaining a Buy rating. * The company reported impressive second-quarter results, surpassing Wall Street expectations, and raised its full-year outlook. * Hinge Health announced a $105 million acquisition of Cylinder Health, expanding into gastrointestinal care.